Aspiriant LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Sell |
1,628
-63
| -4% | -$25.5K | 0.02% | 176 |
|
|
2025
Q1 | $841K | Buy |
1,691
+23
| +1% | +$11.4K | 0.03% | 150 |
|
|
2024
Q4 | $868K | Buy |
1,668
+43
| +3% | +$22.4K | 0.03% | 151 |
|
|
2024
Q3 | $1.01M | Buy |
1,625
+154
| +10% | +$95.3K | 0.04% | 144 |
|
|
2024
Q2 | $813K | Sell |
1,471
-354
| -19% | -$196K | 0.03% | 155 |
|
|
2024
Q1 | $1.06M | Sell |
1,825
-17
| -0.9% | -$9.88K | 0.04% | 142 |
|
|
2023
Q4 | $978K | Sell |
1,842
-173
| -9% | -$91.8K | 0.04% | 147 |
|
|
2023
Q3 | $1.02M | Buy |
2,015
+179
| +10% | +$90.6K | 0.05% | 132 |
|
|
2023
Q2 | $958K | Buy |
1,836
+1
| +0.1% | +$522 | 0.05% | 139 |
|
|
2023
Q1 | $1.06M | Sell |
1,835
-25
| -1% | -$14.4K | 0.06% | 128 |
|
|
2022
Q4 | $1.02M | Buy |
1,860
+276
| +17% | +$152K | 0.05% | 130 |
|
|
2022
Q3 | $805K | Buy |
1,584
+101
| +7% | +$51.3K | 0.04% | 132 |
|
|
2022
Q2 | $805K | Buy |
1,483
+16
| +1% | +$8.69K | 0.04% | 137 |
|
|
2022
Q1 | $866K | Sell |
1,467
-42
| -3% | -$24.8K | 0.05% | 143 |
|
|
2021
Q4 | $1.01M | Buy |
1,509
+22
| +1% | +$14.7K | 0.05% | 132 |
|
|
2021
Q3 | $849K | Sell |
1,487
-72
| -5% | -$41.1K | 0.05% | 127 |
|
|
2021
Q2 | $786K | Sell |
1,559
-52
| -3% | -$26.2K | 0.04% | 131 |
|
|
2021
Q1 | $735K | Buy |
1,611
+19
| +1% | +$8.67K | 0.05% | 124 |
|
|
2020
Q4 | $741K | Buy |
1,592
+54
| +4% | +$25.1K | 0.05% | 124 |
|
|
2020
Q3 | $681K | Buy |
1,538
+8
| +0.5% | +$3.54K | 0.05% | 130 |
|
|
2020
Q2 | $554K | Buy |
+1,530
| New | +$554K | 0.05% | 125 |
|
|
2019
Q3 | – | Sell |
-745
| Closed | -$219K | – | 229 |
|
|
2019
Q2 | $219K | Hold |
745
| – | – | 0.02% | 210 |
|
|
2019
Q1 | $204K | Sell |
745
-264
| -26% | -$72.3K | 0.02% | 220 |
|
|
2018
Q4 | $225K | Buy |
+1,009
| New | +$225K | 0.02% | 210 |
|
|
2018
Q2 | – | Sell |
-992
| Closed | -$205K | – | 262 |
|
|
2018
Q1 | $205K | Buy |
+992
| New | +$205K | 0.02% | 229 |
|